Home

In a significant step toward improving health outcomes, the government of Gandaki Province, with the dedicated support of FAIRMED, has released two essential publications: Leprosy Diagnosis Training Manual and Leprosy Diagnosis Participant Handbook. These publications are expected to strengthen leprosy diagnosis capabilities at the community level, ensuring the disease is detected early and treated effectively.

 FAIRMED contributed to the development and publication of a comprehensive guideline for Self-Help Groups (SHGs) in Lumbini Province. This document aims to strengthen the support system for individuals suffering with challenging conditions, such as lymphatic filariasis, by providing a structured approach to rehabilitation and empowerment.

Baglung, August 6, 2024 — A catastrophic landslide struck the Badigad Rural Municipality in Baglung district, affecting Ward Nos. 9 and 10. The disaster resulted in the tragic loss of 10 lives, leaving another 10 individuals injured, who are now receiving medical treatment in Burtibang, Pokhara, and Kathmandu. The landslide has placed approximately 50 households at severe risk due to the unstable terrain, with many homes teetering on the edge of collapse.

In 2024, Nepal conducted an extensive Mass Drug Administration (MDA) campaign to combat Lymphatic Filariasis (LF) in Kapilvastu and Jhapa, two districts with alarmingly high LF prevalence rates. Despite previous efforts, the Epidemiological Disease Control Division (EDCD) found a high LF prevalence during a 2022 Re-Pre TAS survey, prompting the introduction of a three-drug regimen—IDA (Ivermectin, Diethylcarbamazine, and Albendazole). The campaign, supported by numerous partners, aimed to curb LF transmission and increase community engagement and drug compliance.

 The Health Office of Morang in collaboration with FAIRMED, under the Province Government's Ministry of Health and the Health Directorate, has successfully completed the Morbidity Management and Disability Prevention (MMDP) Mapping for the year 2079/080 (2023).